|
|
||||||||
Journal of Lipid Research, Vol 34, 875-884, Copyright © 1993 by Lipid Research, Inc.
ARTICLES |
G Yoshino, T Hirano, K Nagata, E Maeda, Y Naka, Y Murata, T Kazumi and M Kasuga
Second Department of Internal Medicine, Kobe University School of Medicine, Japan.
This study was conducted to determine whether overproduction of triglyceride-rich lipoprotein is an obligatory factor for experimental hypertriglyceridemia in nephrotic rats. Nephrosis was induced in male Wistar rats by administration of 150 mg/kg puromycin aminonucleoside. Nephrotic rats had slightly increased triglyceride secretion rate (TGSR) estimated using Triton WR1339 (0.53 +/- 0.05 vs. 0.45 +/- 0.04 mg/min, P < 0.05 vs. control rats) and marked hypertriglyceridemia (330.4 +/- 78.6 mg/dl). Rats made diabetic by 40 mg/kg streptozotocin were normotriglyceridemic (66.3 +/- 12.1 mg/dl) but had suppressed TGSR (0.33 +/- 0.09 mg/min). Experimental nephrosis was induced in diabetic rats. Their TGSR remained suppressed (0.35 +/- 0.06 mg/min) but they had marked hypertriglyceridemia (296.6 +/- 72.4 mg/dl) suggesting further impairment of triglyceride removal from the circulation in diabetic rats caused by nephrosis. Endogenously radiolabeled very low density lipoprotein (VLDL)-triglyceride from donor rats was reinjected into normal recipient rats. [3H]VLDL from the experimental groups (the rats with nephrosis, diabetes with nephrosis, and diabetes alone) were more slowly cleared by normal rats than VLDL from normal rats. These results suggest that circulating insulin is essential for increased triglyceride secretion in experimental nephrosis and that nephrotic hypertriglyceridemia can be induced only by a triglyceride removal defect. Therefore, hypersecretion of triglyceride-rich lipoprotein is not an obligatory factor for nephrotic hypertriglyceridemia.
This article has been cited by other articles:
![]() |
T. Hirano, T. Takahashi, S. Saito, H. Tajima, T. Ebara, and M. Adachi Apoprotein C-III deficiency markedly stimulates triglyceride secretion in vivo: comparison with apoprotein E Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E665 - E669. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ikeda, J. Kumamaru, N. Nakatani, M. Sakono, I. Murota, and K. Imaizumi Reduced Hepatic Triglyceride Secretion in Rats Fed Docosahexaenoic Acid-Rich Fish Oil Suppresses Postprandial Hypertriglyceridemia J. Nutr., April 1, 2001; 131(4): 1159 - 1164. [Abstract] [Full Text] |
||||
![]() |
A. Suga, T. Hirano, S. Inoue, M. Tsuji, T. Osaka, Y. Namba, M. Miura, and M. Adachi Plasma leptin levels and triglyceride secretion rates in VMH-lesioned obese rats: a role of adiposity Am J Physiol Endocrinol Metab, April 1, 1999; 276(4): E650 - E657. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Braschi, D. Masson, G. Rostoker, E. Florentin, A. Athias, C. Martin, B. Jacotot, P. Gambert, C. Lallemant, and L. Lagrost Role of Lipoprotein-Bound NEFAs in Enhancing the Specific Activity of Plasma CETP in the Nephrotic Syndrome Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 2559 - 2567. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Journal of Biological Chemistry |
| Molecular and Cellular Proteomics | ASBMB Today |